Literature DB >> 30949889

Are antibiotics a risk factor for the development of necrotizing enterocolitis-case-control retrospective study.

Ali Ahmed Raba1,2, Anne O'Sullivan2, Jana Semberova2,3, Aisling Martin2,4, Jan Miletin5,6,7,8.   

Abstract

Previous studies have identified numerous risk factors associated with necrotizing enterocolitis (NEC) in very low birth weight (VLBW; birth weight less than 1500 g) infants. One of the potential pathophysiological contributors could be antibiotic therapy. Our aim was to explore the association between antibiotic exposure and NEC in VLBW infants. We designed a retrospective 1:2 case-control cohort study in a level III neonatal intensive care unit. Our study group composed of VLBW infants born between January 2012 and December 2014 with a diagnosis of NEC stage IIA or greater (Bell's modified criteria). Our intent was to match every case in the study group to two controls. Our primary outcome was an association between antibiotic exposure and NEC. Twenty-two cases of NEC were matched to 32 controls. The infants who developed NEC were exposed to a statistically significantly more frequent number of antibiotic courses and to more days on any antibiotic prior to the development of NEC. There were significant differences between cases and controls with respect to the duration of exposure to gentamicin and meropenem specifically.
Conclusion: The data from our study demonstrate that prolonged exposure to antibiotic therapy is associated with an increased risk of NEC among VLBW infants. Furthermore, gentamicin and meropenem, but not other antibiotics, had a significant association with the incidence of NEC. What is known: • Early antibiotic exposure is a risk factor for the development of necrotising enterocolitis (NEC) in very low birth weight infants • Prolonged initial empirical antibiotic course for ≥ 5 days, despite sterile blood culture, is associated with an increased risk of developing NEC What is new: • The cumulative total number of days of antibiotic exposure is associated with an increased risk of developing NEC • Gentamicin and meropenem, but not other antibiotics, had a significant association with the incidence of NEC in our study.

Entities:  

Keywords:  Antibiotics; Case-control study; Necrotising enterocolitis; Very-low-birth-weight infant

Mesh:

Substances:

Year:  2019        PMID: 30949889     DOI: 10.1007/s00431-019-03373-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Risk factors for necrotizing enterocolitis and establishment of prediction model of necrotizing enterocolitis in preterm infants.

Authors:  You-Ping Wang; Mei-Yu Zheng; Ye-Ying Xiao; Yang-Ming Qu; Hui Wu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15

Review 2.  Nanomedicine to fight infectious disease.

Authors:  Kathryn M Rubey; Jacob S Brenner
Journal:  Adv Drug Deliv Rev       Date:  2021-10-08       Impact factor: 15.470

3.  Understanding the development and function of the gut microbiota in health and inflammation.

Authors:  Deepak Selvakumar; Dolan Evans; Katharine Z Coyte; John McLaughlin; Andy Brass; Laura Hancock; Sheena Cruickshank
Journal:  Frontline Gastroenterol       Date:  2022-06-15

4.  Risk factors for necrotizing enterocolitis in preterm infants: a Meta analysis.

Authors:  Chun-Yun Lu; Ke-Feng Liu; Gao-Xing Qiao; Yuan Luo; Hui-Qing Cheng; Shu-Zhang DU
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

Review 5.  Role of IgA in the early-life establishment of the gut microbiota and immunity: Implications for constructing a healthy start.

Authors:  Jielong Guo; Chenglong Ren; Xue Han; Weidong Huang; Yilin You; Jicheng Zhan
Journal:  Gut Microbes       Date:  2021 Jan-Dec

6.  Antibiotics in the medical and surgical treatment of necrotizing enterocolitis. A systematic review.

Authors:  Ester Maria Gill; Kristine Jung; Niels Qvist; Mark Bremholm Ellebæk
Journal:  BMC Pediatr       Date:  2022-01-27       Impact factor: 2.125

7.  Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation.

Authors:  Zhen-Hai Shang; Yue-E Wu; Dong-Mei Lv; Wei Zhang; Wen-Qiang Liu; John van den Anker; Yan Xu; Wei Zhao
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

8.  Prolonged antibiotic therapy increased necrotizing enterocolitis in very low birth weight infants without culture-proven sepsis.

Authors:  Keran Zhu; Hui Gao; Liping Yuan; Lili Wang; Fang Deng
Journal:  Front Pediatr       Date:  2022-09-06       Impact factor: 3.569

9.  Determinants of the Very Low-Birth-Weight Infant's Intestinal Microbiome: A Systematic Review.

Authors:  Katelyn Desorcy-Scherer; Marion M Bendixen; Leslie A Parker
Journal:  J Perinat Neonatal Nurs       Date:  2020 Jul/Sep       Impact factor: 2.522

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.